Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 Registries.
Andrea ScottiSara BaggioMatteo PagnesiMarco BarbantiMarianna AdamoAmnon EitanRodrigo Estévez-LoureiroVerena VeulemansStefan ToggweilerDarren MylotteFrederico DeMarcoFrancesco GianniniMarco FerliniChristoph K NaberAndrea BuonoJoachim SchoferWolfgang RottbauerNicolas M D A van MieghemSaib KhogaliMaurizio TaramassoThomas PilgrimJan-Malte SinningDavid ZweikerMatteo MontorfanoJan A S Van der HeydenSalvatore BrugalettaAlfonso IelasiChristian W HammMaarten VanhaverbekeGiuliano CostaMauro MassussiRobert AlarcónTobias ZeusMattia LunardiLuca TestaLuca Di IennoGiuseppe LanzilloAlexander WolfDiego MaffeoFrancesca ZivielloMatteo SaccocciStephan WindeckerAlexander SedaghatAlbrecht SchmidtJorn BrouwerAnder RegueiroBernhard ReimersWon Keun KimLars SondergaardAntonio ColomboAntonio MangieriAzeem Latibnull nullPublished in: Circulation. Cardiovascular interventions (2023)
TAVR with Evolut PRO/PRO+ self-expanding valve is safe and effective. Despite the treatment of heavier calcified anatomies, procedural outcomes are improving over time with less need for pacemaker implantation and less significant paravalvular leaks.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve replacement
- anti inflammatory
- ejection fraction
- heart failure
- left ventricular
- metabolic syndrome
- pulmonary embolism
- adipose tissue
- mitral valve
- coronary artery disease
- weight loss
- skeletal muscle
- atrial fibrillation
- smoking cessation